Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data

The Lancet Infectious Diseases
Aug 2013  Volume 13  Number 8  p639 – 724
http://www.thelancet.com/journals/laninf/issue/current

Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
Dennis Falzon, Ernesto Jaramillo, Fraser Wares, Matteo Zignol, Katherine Floyd, Mario C Raviglione

Preview |
Six countries (Belarus, Brazil, Kazakhstan, Peru, South Africa, and Ukraine) can achieve universal access to MDR-tuberculosis care by 2015 should they sustain their current pace of progress. In other countries a radical scale-up will be needed for them to have an effect on their MDR-tuberculosis burden. Unless barriers to diagnosis and successful treatment are urgently overcome, and new technologies in diagnostics and treatment effectively implemented, the global targets for 2015 are unlikely be achieved.